Technical Analysis for ALT - Altimmune, Inc.

Grade Last Price % Change Price Change
F 9.74 -0.10% -0.01
ALT closed down 0.1 percent on Wednesday, August 4, 2021, on 64 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: Aug 9
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical ALT trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
Multiple of Ten Bearish Other 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup -0.10%
Bollinger Band Squeeze Range Contraction -0.10%
BB Squeeze + Upper Band Touch Range Contraction -0.10%
Above Upper BB Strength -0.10%
Older End-of-Day Signals for ALT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% about 15 hours ago
Possible Pocket Pivot about 17 hours ago
Up 5% about 19 hours ago
60 Minute Opening Range Breakout about 20 hours ago
Up 3% about 20 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Altimmune, Inc. Description

Altimmune,Inc., formerly Pharmathene, Inc., is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company's anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes. The Company's product portfolio includes recombinant butyrylcholinesterase (rBChE) bioscavenger, which is used in prevention and treatment of nerve agent poisoning. The Company has developed a recombinant form of human butyrylcholinesterase for pre- and post-exposure therapy to patients with nerve agent attacks. Its rBChE bioscavenger acts with mechanism, which includes reversal of the acute toxicity associated with organophosphate poisoning agents used in chemical warfare (cholinergic crisis). Its development program also includes Valortim for monoclonal human antibody treatment.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Phosphate Manufacturing Process Vaccine Nerve Reversal Manufacturing Processes Choline Biodefense Biological Warfare Anthrax Chemical Warfare Cholinesterase Anthrax Vaccines Athene

Is ALT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 28.19
52 Week Low 7.8
Average Volume 2,081,898
200-Day Moving Average 13.31
50-Day Moving Average 11.80
20-Day Moving Average 9.12
10-Day Moving Average 9.25
Average True Range 0.73
ADX 20.65
+DI 24.82
-DI 22.98
Chandelier Exit (Long, 3 ATRs) 8.08
Chandelier Exit (Short, 3 ATRs) 10.29
Upper Bollinger Bands 9.80
Lower Bollinger Band 8.43
Percent B (%b) 0.96
BandWidth 14.98
MACD Line -0.64
MACD Signal Line -0.90
MACD Histogram 0.2582
Fundamentals Value
Market Cap 322.11 Million
Num Shares 33.1 Million
EPS -4.16
Price-to-Earnings (P/E) Ratio -2.34
Price-to-Sales 40.41
Price-to-Book 2.12
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.72
Resistance 3 (R3) 10.78 10.53 10.55
Resistance 2 (R2) 10.53 10.28 10.49 10.50
Resistance 1 (R1) 10.13 10.12 10.01 10.07 10.44
Pivot Point 9.88 9.88 9.81 9.84 9.88
Support 1 (S1) 9.48 9.63 9.36 9.42 9.04
Support 2 (S2) 9.23 9.47 9.19 8.98
Support 3 (S3) 8.83 9.23 8.93
Support 4 (S4) 8.77